Background-Atherosclerotic lesions are believed to grow via the recruitment of bone marrow-derived monocytes.
contains a reservoir of undifferentiated monocytes in the steady state, 16 -18 becomes monocytopoietic during atherosclerosis.
Methods
Animals C57BL/6J (wild-type [wt]), B6.SJL-Ptprc a Pep3 b /BoyJ (CD45.1 ϩ ), C57BL/6-Tg(UBC-GFP)30Scha/J (green fluorescent protein-positive [GFP ϩ ]), B6.Cg-Tg(ACTB-mRFP1)1F1Hadj/J (red fluorescent protein-positive [RFP ϩ ]), apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice (B6.129P2-Apoe tm1Unc ), and low-density lipoprotein receptor-deficient (LDLR Ϫ/Ϫ )ApoB48 Ϫ/Ϫ (B6;129S-Apob tm2Sgy Ldlr tm1Her /J) male and female mice were purchased from The Jackson Laboratories. All protocols were approved by the Animal Review Committee at Massachusetts General Hospital. More details are given in the online-only Data Supplement.
Animal Models and In Vivo Interventions
Splenectomy, spleen transplantation, parabiosis, and adoptive transfer of cells are described in detail in the Experimental Procedures section in the online-only Data Supplement. Mice were injected intravenously with blocking antibodies, with clodronate liposomes, or with oxidized LDL, as described in the online-only Data Supplement.
Flow Cytometry
Antibodies used in the study are listed in the online-only Data Supplement. Data were acquired on an LSRII (BD Biosciences) and analyzed with FlowJo version 8.8.6 (Tree Star, Inc). Cells were sorted on a BD FACSAria II (BD Biosciences).
Histology
Aortas and spleens were excised, embedded in optimal-cuttingtemperature compound (Sakura Finetek), and flash-frozen in isopentane and dry ice. Frozen 5-m-thick sections were used in all staining protocols. Immunofluorescence staining was carried out with the protocols described in the online-only Data Supplement.
Intravital Microscopy
Intravital microscopy was performed on exteriorized spleens of live animals. Time-lapse images were captured to visualize the behavior of cells. Details of the procedure are given in the online-only Data Supplement.
Statistics
Results are expressed as meanϮSEM. Statistical tests included unpaired, 2-tailed Student t test with the Welch correction for unequal variances and 1-way ANOVA followed by the Bonferroni comparison test. Values of PՅ0.05 were considered to denote significance.
Results

The Spleen Contributes Ly-6C high Monocytes to the Growing Atheroma
We have previously shown that the spleen contains a monocyte reservoir that mobilizes in response to acute injury, 17 but the role of this reservoir in chronic inflammatory diseases such as atherosclerosis is unknown. We chose to investigate a possible link between the splenic reservoir and atherosclerosis in ApoE Ϫ/Ϫ mice. Immunofluorescent staining, which provides information on spatial distribution, showed expansion of CD11b ϩ cells throughout the red pulp of ApoE Ϫ/Ϫ mice ( Figure 1A) , indicating enlargement of this reservoir. Enumeration of splenic leukocytes in wt C57BL/6 mice and ApoE Ϫ/Ϫ mice consuming a diet high in fat and cholesterol (HCD) revealed dramatic differences between the groups: ApoE Ϫ/Ϫ mice had a marked increase in myeloid but not lymphoid cell number ( Figure Ia and Ib in the online-only mice consuming an HCD 20 weeks, and ApoE Ϫ/Ϫ mice consuming an HCD for 20 weeks and then injected with clodronate liposomes 1 day earlier (nϭ2-10). C, Presence of CD45.1 ϩ cells in the blood of CD45.2 ϩ mice that received CD45.1 ϩ spleens by transplantation. D, Spleen transplantation from CD45.1 ApoE Ϫ/Ϫ donors consuming an HCD to CD45.2 ApoE Ϫ/Ϫ recipients. Data show direct accumulation and differentiation of splenic Ly-6C high monocytes in aortic lesions in 1 day. One of 11 representative experiments is shown. E, Spleen transplantation from CD45.1 ApoE Ϫ/Ϫ donors consuming chow and from CD45.1 ApoE Ϫ/Ϫ donors consuming an HCD and then injected with clodronate liposomes. Data show negligible accumulation of splenic monocytes in aortic lesions in these controls. F, IF on the aortic root with antibodies against CD45.1 (green) and CD11b (red) and the merge of the 2 (yellow). DAPI depicts nuclei (blue). Arrows point to CD11b ϩ cells of splenic origin. For all flow cytometric plots, the ticks represent 0, 10 2 , 10 3 , 10 4 , 10 5 fluorescence units, except for axes labeled "cell no." or "SSC," for which the ticks represent 0, 50 000, 100 000, 150 000, 200 000, and 250 000 fluorescence units.
Data Supplement), a finding that complements previous work. 12 Within the myeloid compartment of the spleen, both monocyte and neutrophil numbers increased (Figure Ic in the online-only Data Supplement). We also detected an expansion of monocytes and neutrophils in the spleens of LDLR Ϫ/ ϪApoB48 Ϫ/Ϫ mice consuming a Paigen diet, indicating that the phenomenon is ApoE independent ( Figure Id in the online-only Data Supplement).
To address whether the spleen mobilizes monocytes during atherogenesis, we transplanted spleens from CD45.1 ApoE Ϫ/Ϫ mice to recently splenectomized 30-week-old CD45.2 ApoE Ϫ/Ϫ mice that had consumed an HCD for 20 weeks. The transplantation procedure anastomoses splenic and recipient vessels, preserves blood flow and organ integrity, 17 and does not alter the relative proportion of endogenous leukocytes in the spleen, bone marrow, and blood (Figure Ie in the online-only Data Supplement). The transplanted spleens resembled endogenous spleens in size and cellularity, had the characteristic purplish-red color, and were well perfused ( Figure If in the online-only Data Supplement). Spleens of CD45.1 ApoE Ϫ/Ϫ mice consuming an HCD for 20 weeks were large and enriched with myeloid cells ( Figure 1B) . As a control, we also transplanted spleens from CD45.1 ApoE Ϫ/Ϫ mice consuming a chow diet (chow) because they contained small spleens and relatively small myeloid reservoirs ( Figure 1B ) and spleens from CD45.1 ApoE Ϫ/Ϫ mice consuming an HCD that had their reservoirs depleted with clodronate liposomes ( Figure 1B) .
Transplantation of CD45.1 ApoE Ϫ/Ϫ mice consuming an HCD for 20 weeks led to a large accumulation of spleen-derived monocytes, but not macrophages, in the recipient blood (4.7ϫ10 5 Ϯ2ϫ10 5 monocytes in blood; Figure 1C ). After 24 hours, 45Ϯ15% of the monocytes found in the blood were splenic derived. Although we focused our analysis on monocytes and progeny (CD11b ϩ Lin 1 Ϫ ; Figure Ia in the online-only Data Supplement), other cells such as neutrophils also accumulated (data not shown). In accordance with the blood data, we observed a substantial population of CD45.1 ϩ cells in the recipient aorta consisting of F4/80 low monocytes and F4/80 high macrophages ( Figure 1D ), thus indicating that spleenexperienced F4/80 low monocytes accumulated in lesions and matured to F4/80 high macrophages locally. The observed contribution of 19% in 24 hours is an underestimation given that an endogenous pool of macrophages already reside in the aorta before transplantation. By focusing on monocytes in the aorta that had recently proliferated, we estimated that the spleen contributed Ϸ30% of monocytes in 1 day. Remarkably, 100% of monocytes arriving from the spleen (ie, CD45.1) were Ly-6C high , whereas monocytes arriving from all other sources (ie, CD45.2) contained a mixture of Ly-6C high and Ly-6C low monocytes. Transplantation of spleens from either of the 2 controls led to a very low accumulation of monocytes and progeny in the aorta ( Figure 1E ). Importantly, the total number of aortic monocytes was similar in ApoE Ϫ/Ϫ HCD spleen recipients compared with age-and diet-matched controls that did not receive a spleen by transplantation ( Figure Ig in the online-only Data Supplement), indicating that the transplantation procedure did not interfere with cell accumulation in the aorta. The finding is expected because the transplantation experiments consisted of removing the endogenous spleen and thus represented splenic exchange rather than supplementation. The intima of aortic root lesions contained spleen-derived myeloid cells of mixed morphology readily identified by CD45.1 immunofluorescence (Figure 1F ). The spleen therefore contributes inflammatory Ly-6C high monocytes to the growing atheromata.
Spleen-Experienced Monocytes Express Pro-Interleukin-1␤, Have Proteolytic Capacity, Contribute Reactive Oxygen Species, and Give Rise to Lipid-Laden Macrophages in Atheromata
Monocyte-derived macrophages in atheromata secrete inflammatory cytokines, express proteolytic enzymes, contribute reactive oxygen species, and ingest lipids. Each of these functions profoundly influences lesion evolution. Inflammatory cytokines and reactive oxygen species propagate inflammation; proteolysis remodels the extracellular matrix; and lipid uptake yields foam cells. 7 We therefore sought to determine whether spleen-experienced monocytes and macrophages exhibit these properties. We compared spleenexperienced monocytes and their descendent macrophages with monocytes and macrophages that arrived from all sources by transplanting CD45.1 ϩ ApoE Ϫ/Ϫ spleens to CD45.2 ϩ ApoE Ϫ/Ϫ animals for 2 days, as shown in Figure 1 . For simplicity, we call these spleen-experienced monocytes and their descendent macrophages "splenic" and those arriving from all sources medullary. It is important to note, however, that at least some of the medullary cells might have experienced the spleen before accumulating in lesions.
Evaluating inflammatory cytokine expression focused on interleukin (IL)-1␤, a monocyte product implicated in many aspects of atherogenesis. 19 Aortic cells in ApoE Ϫ/Ϫ HCD mice expressed a higher proportion of pro-IL-1␤ ϩ compared with wt controls ( Figure IIa and IIb in the online-only Data Supplement), reflecting the higher inflammatory burden of these animals. Spleen transplantation revealed similar pro-IL-1␤ expression among splenic (CD45.1 ϩ ) and medullary (CD45.2 ϩ ) monocytes, suggesting that the inflammatory capacity of splenic monocytes is comparable to that of their counterparts ( Figure 2A ). Splenic (CD45.1 ϩ ) aortic macrophages remained pro-IL-1␤ ϩ at proportions similar to those of monocytes but at higher proportions than CD45.2 ϩ macrophages. This indicates that aortic monocytes and macrophages of splenic origin are at least as, if not more, inflammatory as their CD45.2 ϩ counterparts. To investigate proteolysis, we injected spleen recipients with a proteaseactivatable fluorescent sensor that reports on cysteinyl cathepsin activity in vivo. 20, 21 At the cellular level, most lesional monocytes and macrophages of splenic origin (CD45.1 ϩ ) exhibited proteolytic activity, and comparison with lesional monocytes and macrophages accumulating from the bone marrow (CD45.2 ϩ ) revealed a similar proportion (83% versus 78%; 98% versus 85% were positive for Prosense-680) of signal ( Figure 2B ). Monocytes had less proteolytic activity when residing in the bone marrow and spleen, indicating that proteolysis coincides with activation in destination sites ( Figure IIc in the online-only Data Supplement). To measure cellular redox states, we used an intracellular probe that measures oxidative stress. 22 Regardless of origin, monocytes and macrophages expressed reactive oxy-gen species, although macrophages derived from spleenexperienced monocytes expressed them at somewhat lower levels ( Figure 2C ). Finally, we asked whether spleenexperienced monocytes can give rise to lesional foam cells. Circulating monocytes of either origin accumulated DiIoxidized LDL to the same extent ( Figure IId The spleen is a secondary lymphoid organ that supports multiple functions: It contains T and B cells that participate in adaptive immunity and macrophage and dendritic cell subsets that scavenge erythrocytes and screen for blood-borne infections. 23 In animal models, splenectomized mice 24, 25 and hamsters depleted of monocytes with clodronate liposomes develop larger lesions. 26 We therefore wondered whether and how splenectomy alters the lesional monocyte/macrophage/ foam cell content. As expected, lesions in female mice splenectomized for 12 weeks were larger ( Figure 2F ) as assessed by hematoxylin and eosin staining ( Figure IIf in the online-only Data Supplement). However, the lesions appeared to be less cellular, prompting us to evaluate their content with macrophage markers. Staining for Mac3, CD11b, and F4/80 revealed that aortic root sections in Figure 2K and 2L).Our studies are in accordance with the observation that, when monocyte supply is reduced, lesions become larger and less cellular. 26 Thus, the spleen provides a surplus of cells that serve to shape the evolving lesion.
The Spleen Contains Proliferating Myeloid Cell Progenitors That Give Rise to Their Progeny In Vivo
The cell tracking experiments described thus far may simply reflect production of monocytes in the bone marrow, their circulation through the spleen, and their eventual accumulation in the lesions. We therefore sought to determine whether the spleen can produce monocytes from progenitors. In vitro, splenocytes of ApoE Ϫ/Ϫ HCD mice formed many more granulocyte/macrophage colonies than wt controls ( Figure  3A) , indicating clonal myeloid cell proliferation. Compared with wt controls, ApoE Ϫ/Ϫ HCD mice contained numerous HSPCs, including LSK (Lin 2
Ϫ Sca-1 ϩ c-kit ϩ ) cells and common myeloid progenitors, as well as granulocyte and macrophage progenitors (GMPs), which are the most committed progenitors known to give rise to monocytes and neutrophils 4 ( Figure 3B and Figure IIIa in the online-only Data Supplement). Common lymphoid progenitors did not increase in ApoE Ϫ/Ϫ HCD mice, indicating a preference toward the myeloid lineage in the spleen ( Figure IIIa in the online-only Data Supplement). GMP enumeration over 30 weeks of diet showed continued growth in the spleen. The GMP population in the bone marrow also grew, but less markedly and transiently ( Figure 3C ). Indeed, in many older animals, the GMP population in the spleen exceeded that of the bone marrow. Notably, although the spleen also contained macrophage and dendritic cell progenitors, 27 the aorta and para-aortic lymph nodes were virtually devoid of HSPCs (data not shown). In keeping with the expanded reservoir, the spleens of LDLR Ϫ/Ϫ ApoB48 Ϫ/Ϫ mice also contained higher numbers of GMPs ( Figure IIIb in the online-only Data Supplement). These findings demonstrate that the spleens of atherosclerotic mice contain the requisite myelopoietic cells. To test for monocytopoiesis in vivo, we injected 1ϫ10 5 highly purified GFP-expressing GMP ( Figure IIIc in the online-only Data Supplement) into either ApoE Ϫ/Ϫ HCD or wt mice and enumerated GFP ϩ cells 5 days later. Considerably more GFP ϩ cells accumulated in the spleens of ApoE Ϫ/Ϫ HCD mice than in the controls ( Figure 3D and 3E ). Among these cells, we detected progenitors and differentiated CD11b ϩ Gr1 ϩ monocytes and neutrophils ( Figure IIId in the online-only Data Supplement), which indicates GMP expansion. The number of GFP ϩ cells accumulating in the bone marrow, however, was similar in wt and ApoE Ϫ/Ϫ HCD mice ( Figure 3E ). This similarity likely reflects a preference for mobilized progenitors to seed the spleen in atherosclerosis (progenitors were injected intravenously).
To demonstrate that the spleen contributes rather than simply collects monocytes, we performed spleen transplantation experiments for longer durations. The monocyte half-life is estimated at a few hours to 1 to 2 days, 11, 28 and adoptive transfer of 5ϫ10 6 sorted monocytes by a procedure that allows their retrieval 1 day later 12 failed to yield any cells in lesions, blood, or spleen 5 days later. We therefore reasoned that if monocytes and their progenitors reside in the spleen briefly or simply circulate through its fenestrated parenchyma, spleen transplantation would result in a rapid and complete cell turnover. If, however, the spleen produces monocytes, it should maintain progenitors and monocytes from the original animal for a period exceeding 2 days. In accordance with the second possibility, CD45.2 ϩ ApoE Ϫ/Ϫ HCD mice that received CD45.1 ϩ ApoE Ϫ/Ϫ spleens 10 days earlier contained 3.2ϫ10 6 GMPs, of which 25% were still CD45.1 ϩ ( Figure 3F ), and many were proliferating ( Figure  3G ). The aortas of these mice also contained numerous CD45.1 ϩ monocytes and macrophages ( Figure 3H ). Importantly, that 75% of GMPs that were CD45.2 ϩ in these animals indicates that the bone marrow continuously supplies and replenishes the splenic progenitor pool. In contrast, transplantation of naïve spleens, which do not contain progenitors, resulted in complete turnover of the monocyte pool in 2 days. Thus, if the bone marrow is the upstream source of hematopoietic cells, the spleen is a seeding ground for an amplification cascade during inflammation. Together, our findings indicate that the spleen contains proliferating myeloid cell progenitors that give rise to their progeny in vivo.
Splenic Monocytopoiesis Gives Rise to Lesion-Infiltrating Monocytes
Having established that the spleen contains proliferating hematopoietic progenitors, we next sought to determine more directly whether the spleen supports monocytopoiesis. We injected GFP ϩ GMPs into age-and diet-matched spleencontaining and asplenic ApoE Ϫ/Ϫ HCD mice. Compared with controls, asplenic recipients accumulated fewer GFP ϩ CD11b ϩ cells in the blood and aorta ( Figure 4A and 4B) . In the aorta, among the GFP ϩ cells, we found differentiated monocytes and mature macrophages but not progenitors, which would appear in the lower-left quadrant (CD11b Ϫ MHCII/CD11c/F4/80 Ϫ ; Figure 4C ), indicating a direct and spleen-dependent link from hematopoietic progenitors to tissue descendants. We confirmed these flow cytom-etry tracking experiments by detecting adoptively transferred CD45.1 ϩ F4/80 ϩ cells microscopically on tissue sections ( Figure 4D) .
To confirm the role of the spleen in maintaining the aortic pool of monocytes, we joined CD45.1 to CD45.2 mice by parabiosis ( Figure 4E ), a technique that establishes a shared circulation by which bone marrow HSPCs can seed partner tissues. 5, 6, 17, 28 Two weeks after parabiont separation, the percent of myeloid cell chimerism in wt aortas was low (Ϸ5%) and spleen independent ( Figure 4E ). This finding supports the observation that, under normocholesterolemic conditions, the spleen does not produce monocytes. 17 In contrast to wt mice, the aortas of spleen-containing ApoE Ϫ/Ϫ HCD animals showed a 3-fold increase in chimerism. Strik- A representative contour plot shows that GFP ϩ cells that were injected as GMPs have accumulated in lesions as monocytes and matured to macrophages. D, CD45.1 GMPs were adoptively transferred to ApoE Ϫ/Ϫ HCD mice, and the aorta was harvested 5 days after transfer. A representative pictograph shows CD45.1 (GMP-derived, green), F4/80 (macrophages, red), and their merge (yellow) in the intima. E, CD45.1 and CD45.2 wild-type (wt) or ApoE Ϫ/Ϫ HCD mice were joined in parabiosis for 3 weeks, separated, splenectomized (or not), and assessed for chimerism 2 weeks later. Data show chimerism for CD11b ϩ cells in the aorta (meanϮSEM; nϭ4). ingly, splenectomy decreased this chimerism by nearly 50%. These data demonstrate, by an independent approach, that the spleen contributes myeloid cells to the atherosclerotic aorta.
Granulocyte Macrophage Colony-Stimulating Factor and IL-3 Promote Survival and Proliferation of Progenitor Cells and Their Progeny
The growth factors granulocyte macrophage colonystimulating factor (GM-CSF) and IL-3 can stimulate hematopoiesis, particularly emergency hematopoiesis, 29 but their role in atherosclerosis is poorly understood. 30 -32 Recent observations in experimental atherosclerosis that HSPCs increase the common receptor subunit for GM-CSF and IL-3 33 prompted us to investigate the influence of these cytokines on myelopoiesis. GM-CSF-and IL-3-producing cells increased preferentially in the spleen during atherosclerosis ( Figure 5A ). In the spleen, the red pulp of ApoE Ϫ/Ϫ HCD mice contained numerous GM-CSF-and IL-3-producing cells that stained specifically for the growth factors on tissue sections ( Figure 5B and Figure IVa against GM-CSF and IL-3 on 5 consecutive days and evaluated the myeloid lineage in the spleen, bone marrow, and blood in vivo using 4 approaches. First, we analyzed splenic GMPs. Neutralization of IL-3, GM-CSF, or both increased the proportion of GMPs undergoing apoptosis in situ (as measured by DNA content) and correspondingly decreased their total number in the spleen ( Figure 5C ). Second, we performed pulse-chase experiments that, as in those depicted in Figures 3 and 4 , involved the transfer and retrieval of GFP ϩ cells. Neutralization of IL-3, GM-CSF, or both prevented the appearance of numerous myeloid cells in the spleen and blood ( Figure 5D ). Third, we evaluated the survival and proliferation of mature myeloid cells in the spleen. Again, neutralization increased the proportion of in situ dying monocytes and neutrophils and decreased their local proliferation ( Figure 5E ). Finally, we evaluated the endogenous number of myeloid cells in spleen and blood and found that neutralization attenuated splenic and blood monocytosis and neutrophilia by up to 80% ( Figure 5F ). In vitro confirmatory experiments showed that myelopoiesis was attenuated with only a single dose of GM-CSF-and IL-3neutralizing antibodies ( Figure 5G ). Expectedly, the dramatic decrease in vivo resulted not only from local effects on the spleen, but also from effects on the bone marrow ( Figure IVc in the online-only Data Supplement). These data demonstrate that GM-CSF and IL-3 orchestrate the survival and proliferation of myeloid progenitors and their descendants in the bone marrow and spleen in atherosclerosis.
Extramedullary Hematopoiesis Occurs in Response to Peritoneal Endotoxin Challenge and Can Be Visualized In Vivo
Experiments thus far have shown that, in experimental atherosclerosis, HSPCs accumulate in the spleen and proliferate in response to GM-CSF and IL-3 and the spleen contributes monocytes to the growing atheromata. We next sought to determine whether the process occurs in a different model and whether it can be visualized in vivo. Mice that received lipopolysaccharide daily for 4 days developed visibly larger spleens ( Figure Va in the online-only Data Supplement) containing plenty of monocytes (11-fold expansion over steady state) and neutrophils (23-fold expansion; Figure Vb in the online-only Data Supplement) that resided in the red pulp ( Figure Vc in the online-only Data Supplement). To evaluate whether the spleen contributes newly made neutrophils and monocytes in this model, we first enumerated hematopoietic progenitor cells. In response to lipopolysaccharide, GMPs expanded in the spleen (Ϸ62-fold; Figure Vd We therefore tested whether splenic GMPs give rise to their progeny. Pulse-chase experiments involving the intravenous transfer of GFP-or RFP-expressing GMPs to nonirradiated (wt) C57BL/6 mice that were naïve or that received lipopolysaccharide permitted us to track cell fate by flow cytometry and intravital microscopy. GMPs injected into naïve mice gave rise to only a few progeny ( Figure 6A ). Injection of GMP to mice that received lipopolysaccharide, in contrast, led to marked cellular expansion. Three days after transfer, the fluorescent (in this case, GFP ϩ ) cells in the spleen were still mostly CD11b Ϫ Gr1 Ϫ progenitors, although a few fluorescent neutrophils and a few Ly-6C high monocytes (CD11b ϩ Gr1 ϩ cells) emerged in the circulation ( Figure 6A ). Three to 5 days later (day 6 -8), the fluorescent cells in the spleen and blood were almost exclusively CD11b ϩ Gr1 ϩ neutrophils with a few monocytes but not progenitors, mature macrophages, or dendritic cells ( Figure 6A and 6B). Enumeration revealed significant expansion of neutrophils and monocytes in response to lipopolysaccharide in the spleen and blood ( Figure 6C ). The bone marrow contained numerous GFP progeny, but as reported in the atherosclerosis model, there was no increase in their number in response to lipopolysaccharide. These data show that escalation of the neutrophil and monocyte response in response to endotoxin is associated with an increase in biologically active progenitors in the spleen.
Intravital microscopy showed that GMPs gave rise to clusters of cells that resided outside the blood vessels in the red pulp ( Figure 6D ). In this pulse-chase experiment, clusters appeared 3 days after adoptive transfer, increased in size by 8 days, and disappeared by 12 days (Figure Vg and Vh in the online-only Data Supplement), which is in keeping with the expected lifespan of GMPs. 34 GFP GMPs and RFP GMPs coinjected in equal numbers ( Figure 6E ) gave rise to clusters that were exclusively red or exclusively green, indicating that GMPs seeded the spleen, proliferated clonally, and differentiated locally ( Figure 6F and Figure Vi -Vk in the online-only Data Supplement). Time-lapse imaging of representative clusters showed that locally produced cells can intravasate and thus contribute to the systemic repertoire ( Figure 6G ). To enumerate this contribution, mice were subjected either to splenectomy ( Figure 6H ) or to spleen transplantation ( Figure 6I ). Both approaches revealed that a substantial number of myeloid cells accumulating in the peritoneum were of splenic origin. The cells were inflammatory, as evidenced by the expression of tumor necrosis factor-␣ ( Figure 6J ). Together, these data reveal that extramedullary sites such as the spleen can produce circulating monocytes and neutrophils that accumulate in their respective inflammatory destinations. The model that describes the findings of this study is shown in Figure 7 .
Discussion
The motivation for the present study rested on 2 landmark articles published in the 1960s. The first laid the foundation that HSPCs circulate in the blood rather than simply reside in the bone marrow, 35 whereas the second argued that, in the steady state, the bone marrow is the exclusive monocyte production site. 36 Multiple studies since have enriched our understanding of these processes. Extramedullary hematopoiesis occurs in development and in a number of genetic and myeloproliferative conditions. [37] [38] [39] [40] [41] It involves several discrete steps: (1) Bone marrow HSPCs mobilize; (2) mobilized HSPCs seed extramedullary sites; and (3) seeded HSPCs proliferate and mature. The cell types that have been described to arise through extramedullary hematopoiesis are terminally differentiated, and many are tissue resident. Mono-cytes, on the other hand, are intermediate, circulating cells, developmentally downstream of HSPCs but upstream of dendritic cells and macrophages. 2 Our study places extramedullary hematopoiesis in a larger context not only because it shows that a GM-CSF-and IL-3-rich splenic environment can produce monocytes and neutrophils that then circulate but also because it illustrates an extramedullary cascade in which HSPC proliferation, differentiation, and terminal maturation are compartmentalized in different organs. In atherosclerosis, our data imply, the bone marrow outsources the production of circulating leukocytes.
Of all the organs, the spleen may be an ideal outsource destination. The organ has an open circulation, allowing fast exchange with the blood, 23 yet it is capable of cell retention through myriad adhesive ligands. 42, 43 The organ can accommodate vast quantities and fluctuations of cells, especially in the red pulp. It also allows the rapid exit of undifferentiated monocytes, indicating that entry into its parenchyma neither forces differentiation nor precludes recirculation. 17 Thus, location, elasticity, and architecture render the spleen a perfect seeding ground for the emergency production of inflammatory cells.
It is unknown whether extramedullary hematopoiesis is important in the development of human atherosclerosis. The extent to which the spleen contributes to disease, however, has received some attention. The organ may be dispensable, but it is not unimportant. In humans, splenectomy heightens the risk of infection and ischemic heart disease, probably as a result of multiple mechanisms involving platelets, B cells, T cells, and many of the other components that constitute the organ. 44 The observations made here in response to hypercholesterolemia or endotoxin indicate a role for the spleen in supplying Ly-6C high monocytes, which are known to be inflammatory and proteolytic. We show that, by eliminating this splenic source, lesions become less cellular, although how this particular profile translates to lesion stability requires further study. Future studies also need to elucidate how specific splenic functions can be targeted therapeutically and how other functions such as the protective function of B1 B cells 24 can be spared.
That extramedullary generation of Ly-6C high monocytes occurs during atherosclerosis, when hypercholesterolemia forces a continuous leukocyte supply, is worth further discussion. The steady-state spleen houses a reservoir of undifferentiated monocytes that are, in the absence of neighboring splenic HSPCs, bone marrow derived. The contribution of extramedullary monocytopoiesis during inflammation may be exclusively numeric; with repetitive demand, the organism outsources the production of otherwise identical cells. Alternatively, splenic monocytes, produced in an inflammatory GM-CSF-and IL-3-rich environment, may differ qualitatively from their medullary counterparts. In the present study, we show that monocytes born in extramedullary sites belong to the inflammatory subset and express cytokines, reactive oxygen species, and proteases. They are thus functional and are known to promote the generation of lesions. Future studies need to determine whether splenic birth or experience influences these cells in additional ways.
HSPC mobilization is important to immunosurveillance and likely plays a role in bone marrow niche reconstruction. 5, 45 HSPC differentiation in extramedullary sites may be essential to the replenishment of dendritic cells and macrophages. 46 The extramedullary HSPC production of circulating cells, we now show, contributes importantly to inflammatory diseases. This shift in the hematopoietic topographical hierarchy during inflammation is likely to have significant biological, diagnostic, and therapeutic implications. Figure 7 . Model depicting the extramedullary generation of monocytes in inflammation. Model shows that mobilized hematopoietic stem and progenitor cells accumulate in the splenic red pulp and give rise to monocytes via interleukin-3 (IL-3) and granulocyte macrophage colony-stimulating factor (GM-CSF). Spleen-derived monocytes infiltrate inflammatory sites and mature to macrophages. The splenic contribution increases as the reservoir enlarges. Monocytes that accumulate from bone marrow directly are omitted in this cartoon. ROS indicates reactive oxygen species.
